The statistically significant difference was observed in BCR between the higher and lower CD204+ cell count in the main tumor area, which suggested that a higher CD204+ cell count in the main tumor area predicted a worse prognosis for PCa with SVI (p = 0.042, Fig. 1c). The gene discussed is MSR1; the disease is posterior cortical atrophy.